The real concern for your future
24.03.2016
Experience in using labeled zoledronic acid-based radiopharmaceuticals in patients with metastatic skeletal involvement
The mechanisms for the development of metastatic skeletal lesion and the role of N-bisphosphonates in its therapy
Experience with Rezoscan, 99mTc, used in the diagnosis of metastatic bone involvement
Other articles about the drug:
Articles on drug in PDF
